Data

Study: Paxlovid cuts hospitalization, death only in at-risk COVID patients with weak immune systems seb_ra / iStock CIDRAP

...in JAMA Network Open, an observational Canadian study ties the antiviral drug combo nirmatrelvir-ritonavir (Paxlovid) to a lower risk of hospitalization or death only in very high-risk COVID-19 patients with weakened immune systems.

...

US COVID markers show more declines

Most of the measures the Centers for Disease Control and Prevention (CDC) uses to track COVID-19 activity declined last week, except for deaths, which are often a lagging indicator, according to the group's latest data updates. The levels reflect a recent drop in COVID activity, following several weeks of a slow summer rise from very low levels.

...the World Health Organization (WHO) posted its latest monthly update, which it cautions is based on limited data, with cases and deaths reported from only 96 countries and even fewer countries regularly reporting hospitalizations and intensive care unit (ICU) admissions. It also said its assessments are limited by reduced testing and delays in reporting.

...

Study: 75% of infants hospitalized with COVID-19 born to unvaccinated women ProStock-Studio/iStock CIDRAP

This week, studies in Morbidity and Mortality Weekly Report describe the landscape of COVID-19 vaccination among women of reproductive age and those who are pregnant, showing better outcomes for infants whose mothers were vaccinated during pregnancy.

...